Abstract:Background: Cardiac hypertrophy is a key biological response to injurious stresses such as pressure overload and when excessive can lead to heart failure. Innate immune activation by danger signals, through intracellular pattern recognition receptors such as nucleotide-binding oligomerization domain-containing protein 1(Nod1) and its adaptor receptor-interacting protein 2 (RIP2), might play a major role in cardiac remodeling and progression to heart failure. We hypothesize that Nod1/RIP2 are major contributors to cardiac hypertrophy, but may not be sufficient to fully express the phenotype alone. Methods: To elucidate the contribution of Nod1/RIP2 signaling to cardiac hypertrophy, we randomized Nod1 -/- , RIP2 -/- or wild-type (WT) mice to transverse aortic constriction (TAC) or sham operations. Cardiac hypertrophy, fibrosis, and cardiac function were examined in these mice. Results: Nod1 and RIP2 proteins were up-regulated in the heart after TAC, and this was paralleled by increased expression of mitochondrial proteins, including mitochondrial antiviral signaling protein (MAVS). Nod1 -/- and RIP2 -/- mice subjected to TAC exhibited better survival, improved cardiac function and decreased cardiac hypertrophy. Downstream signal transduction pathways that regulate inflammation and fibrosis including NF-κB and MAPK-GATA4/p300, were reduced in both Nod1 -/- and RIP2 -/- mice after TAC compared with WT mice. Co-immunoprecipitation of extracted cardiac proteins and confocal immunofluorescence microscopy showed that Nod1/ RIP2 interaction was robust and that this complex also included MAVS as an essential component. Suppression of MAVS expression attenuated the complex formation, NF-κB signalling and myocyte hypertrophy. Interrogation of mitochondrial function compared in the presence or ablation of MAVS revealed that MAVS serves to suppress mitochondrial energy output and mediate fission/fusion related dynamic changes. The latter is possibly linked to mitophagy during cardiomyocytes stress, which may provide an intriguing link between innate immune activation and mitochondrial energy balance under stress or injury conditions. Conclusions: We have identified that innate immune Nod1/RIP2 signaling is a major contributor to cardiac remodeling following stress. This process is critically joined by and regulated through the mitochondrial danger signal adapter MAVS. This novel complex coordinates remodeling, inflammatory response and mitochondrial energy metabolism in stressed cardiomyocytes. Thus Nod1/RIP2/MAVS signaling complex may represent an attractive new therapeutic approach toward heart failure.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the molecular mechanism of cardiac hypertrophy, especially the role of the innate immune signaling pathway in this process. Specifically, the researchers explored how the Nod1/RIP2 signaling pathway affects the development of cardiac hypertrophy through its interaction with the mitochondrial antiviral - signaling protein (MAVS). The main research questions can be summarized as follows: 1. **The role of Nod1/RIP2 in cardiac hypertrophy**: The researchers hypothesized that Nod1/RIP2 are the main contributors to cardiac hypertrophy, but other factors may be required to fully express the phenotype. 2. **The role of MAVS in the Nod1/RIP2 signaling pathway**: The researchers found that the Nod1/RIP2 signaling pathway plays a crucial role in cardiac hypertrophy, but this process requires the participation of MAVS. As a key protein on mitochondria, can MAVS regulate the Nod1/RIP2 signaling pathway and play an important role in the process of cardiac hypertrophy? 3. **The function of the Nod1/RIP2/MAVS complex**: The researchers further explored the specific functions of the Nod1/RIP2/MAVS complex in cardiac hypertrophy, including its roles in the inflammatory response, fibrosis, and mitochondrial energy metabolism. 4. **Potential therapeutic targets**: By revealing the mechanism of action of the Nod1/RIP2/MAVS complex in cardiac hypertrophy, the researchers hope to find new potential targets for the treatment of heart failure. ### Main findings - **The expression of Nod1 and RIP2 is up - regulated in cardiac hypertrophy**: In human heart failure and mouse pressure - overload models, the expression of Nod1 and RIP2 is significantly increased. - **The deletion of Nod1 and RIP2 alleviates cardiac hypertrophy**: Mice with Nod1 and RIP2 gene knockout showed better survival rates, improved cardiac function, and reduced cardiac hypertrophy after pressure overload. - **The Nod1/RIP2 signaling pathway is mediated by MAVS**: Nod1 and RIP2 regulate the inflammatory response and fibrosis in the process of cardiac hypertrophy by forming a complex with MAVS. - **The effect of MAVS on mitochondrial function**: The deletion of MAVS enhances the energy output of mitochondria and reduces the production of mitochondrial reactive oxygen species, which may be related to mitochondrial dysfunction in the process of cardiac hypertrophy. ### Conclusion The researchers found that the Nod1/RIP2 signaling pathway plays a crucial role in cardiac hypertrophy, and this process requires the participation of MAVS. The Nod1/RIP2/MAVS complex not only regulates the inflammatory response and fibrosis of cardiac hypertrophy but also affects the energy metabolism of mitochondria. These findings provide new potential targets for the treatment of heart failure.

Innate Immune Nod1/RIP2 Signaling is Essential for Cardiac Hypertrophy, but Requires Mitochondrial Antiviral Signaling Protein (MAVS) for Signal Transductions and Energy Balance